[{"data": {"name": "Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Antoine Tarral", "@type": "Person"}, {"name": "S\u00e9verine Blesson", "@type": "Person"}, {"name": "Olaf Valverde Mordt", "@type": "Person"}, {"name": "Els Torreele", "@type": "Person"}, {"name": "Daniela Sassella", "@type": "Person"}, {"name": "Michael A. Bray", "@type": "Person"}, {"name": "Lionel Hovsepian", "@type": "Person"}, {"name": "Eric Ev\u00e8ne", "@type": "Person"}, {"name": "Virginie Gualano", "@type": "Person"}, {"name": "Mathieu Felices", "@type": "Person"}, {"name": "Nathalie Strub-Wourgaft", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://link.springer.com/content/pdf/10.1007%2Fs40262-014-0136-3.pdf", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4037587?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1007/s40262-014-0136-3", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCdCLzSWjtKDi-CTm4x2AhVXR1a-CDdQKQqFRyAf8-CR1h4gqrkMiCd", "propertyID": "ISCC"}], "datePublished": "2014-02-18"}, "schema": "schema.org", "mediatype": "application/ld+json"}]